Scientist identifies gene responsible for spread of prostate cancer

A Rutgers study has found that a specific gene in cancerous prostate tumors indicates when patients are at high-risk for the cancer to spread, suggesting that targeting this gene can help patients live longer. The study, which was published in the journal Nature Communications, identified the NSD2 gene through a computer algorithm developed to determine which cancer genes that spread […]

Read more

These four symptoms indicate prostate cancer

What are the symptoms that indicate a change in the prostate? Prostate cancer is the most common cancer in men. Every year, around 60,000 new cases occur. According to information of the German cancer society every fourth Tumor in men develops in the prostate. Approximately 10 percent of the cases end fatally. Thus, the prostate cancer, together with lung and […]

Read more

New jab may be a game changer for prostate cancer patients

New jab may be a game changer for thousands of prostate cancer patients Scientists at King’s College London invent new jab to fight prostate cancer cells They will create a man-made version of a naturally occurring protein called IL-15 They aim to start a trial involving 20 men with advanced prostate cancer at Guy’s Hospital in London next year A […]

Read more

Men with prostate cancer willing to accept lower survival odds to avoid side effects

Men who have been newly diagnosed with prostate cancer say they would trade some improvement in their odds of survival for improvements in side effects and quality of life, according to research presented at the 2018 NCRI Cancer Conference. Prostate cancer is one of the most common forms of the disease in men but in many cases it is a […]

Read more

Hypofractionated Radiation OK for Localized Prostate CA

MONDAY, Oct. 29, 2018 — A new clinical guideline for early-stage prostate cancer supports the use of shortened courses of radiation therapy, according to an article published in Practical Radiation Oncology. Scott C. Morgan, M.D., from the University of Ottawa in Canada, and colleagues conducted a systematic literature review to develop recommendations regarding moderately hypofractionated (240-340 cGy per fraction) and […]

Read more